Compounds > tretazicar

Page last updated: 2024-08-26

tretazicar and Experimental Neoplasms

tretazicar has been researched along with Experimental Neoplasms in 11 studies

Research

Studies (11)

Timeframe	Studies, this research(%)	All Research%
pre-1990	5 (45.45)	18.7374
1990's	1 (9.09)	18.2507
2000's	3 (27.27)	29.6817
2010's	1 (9.09)	24.3611
2020's	1 (9.09)	2.80

Authors

Authors	Studies
Chang, D; Chang, HF; Chen, BM; Chen, SH; Chen, TC; Collins, S; Kasahara, N; Lin, SC; Lu, YC; Sun, JM; Tai, CK; Wang, HE; Wang, W; Wu, SF	1
Ackerley, DF; Chan-Hyams, JV; Copp, JN; Little, RF; Mowday, AM; Patterson, AV; Rich, MH; Smaill, JB; Williams, EM	1
Braidwood, L; Brown, SM; Dunn, PD; Evans, TR; Hardy, S	1
Walton, MI; Workman, P	1
Bailey, SM; Hart, IR	1
Dexter, MT; Djeha, AH; Hulme, A; Kerr, DJ; Mountain, A; Searle, PF; Wrighton, CJ; Young, LS	1
Kestell, P; Palmer, BD; Pruijn, FB; Siim, BG; Wilson, WR	1
Boland, MP; Friedlos, F; Knox, RJ; Kotsaki-Kovatsi, VP; Marchbank, T; Roberts, JJ	1
Chaplin, DJ	1
Talbot, K; White, RA; Workman, P	1
Donaldson, J; Morgan, JE; Talbot, K; Twentyman, PR; Workman, P; Wright, KA	1

Reviews

1 review(s) available for tretazicar and Experimental Neoplasms

Article	Year
Nitroreductase gene-directed enzyme prodrug therapy: insights and advances toward clinical utility. The Biochemical journal, 2015, Oct-15, Volume: 471, Issue:2 Topics: Animals; Aziridines; Directed Molecular Evolution; Escherichia coli Proteins; Genetic Therapy; Humans; Neoplasms, Experimental; Nitroreductases; Prodrugs	2015

Other Studies

10 other study(ies) available for tretazicar and Experimental Neoplasms

Article	Year
Efficient Prodrug Activator Gene Therapy by Retroviral Replicating Vectors Prolongs Survival in an Immune-Competent Intracerebral Glioma Model. International journal of molecular sciences, 2020, Feb-20, Volume: 21, Issue:4 Topics: Animals; Aziridines; Brain Neoplasms; Cell Line, Tumor; Cytosine Deaminase; Escherichia coli Proteins; Flucytosine; Genetic Therapy; Genetic Vectors; Glioma; Leukemia Virus, Gibbon Ape; Neoplasms, Experimental; Nitroreductases; Prodrugs; Rats, Inbred F344; Saccharomyces cerevisiae Proteins	2020
Antitumor activity of a selectively replication competent herpes simplex virus (HSV) with enzyme prodrug therapy. Anticancer research, 2009, Volume: 29, Issue:6 Topics: Animals; Antineoplastic Agents; Aziridines; Blotting, Western; Combined Modality Therapy; Female; Herpes Simplex; Herpesvirus 1, Human; Humans; Immunoenzyme Techniques; Mice; Mice, Nude; Neoplasms, Experimental; Oncolytic Viruses; Polymerase Chain Reaction; Prodrugs; Tissue Distribution; Virus Replication	2009
Pharmacology of the mixed-function radio- and chemosensitizers CB 1954 and RSU 1069. International journal of radiation oncology, biology, physics, 1984, Volume: 10, Issue:8 Topics: Animals; Aziridines; Azirines; Brain; Drug Synergism; Female; Male; Metabolic Clearance Rate; Mice; Mice, Inbred Strains; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Radiation-Sensitizing Agents; Time Factors	1984
Nitroreductase activation of CB1954--an alternative 'suicide' gene system. Gene therapy, 1997, Volume: 4, Issue:2 Topics: Animals; Antineoplastic Agents; Aziridines; Genetic Therapy; Mice; Neoplasms, Experimental; Nitroreductases; Prodrugs; Tumor Cells, Cultured	1997
Expression of Escherichia coli B nitroreductase in established human tumor xenografts in mice results in potent antitumoral and bystander effects upon systemic administration of the prodrug CB1954. Cancer gene therapy, 2000, Volume: 7, Issue:5 Topics: Animals; Apoptosis; Aziridines; Carcinoma, Hepatocellular; Carcinoma, Squamous Cell; Cross-Linking Reagents; Dose-Response Relationship, Drug; Escherichia coli; Head and Neck Neoplasms; Humans; Immunohistochemistry; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Necrosis; Neoplasm Transplantation; Neoplasms, Experimental; Nitroreductases; Prodrugs; Remission Induction; Time Factors; Tumor Cells, Cultured	2000
Pharmacokinetics and metabolism of the nitrogen mustard bioreductive drug 5. Cancer chemotherapy and pharmacology, 2000, Volume: 46, Issue:5 Topics: Aniline Mustard; Animals; Antineoplastic Agents; Aziridines; Biotransformation; Chromatography, High Pressure Liquid; Injections, Intravenous; Injections, Subcutaneous; Male; Mice; Mice, Inbred C3H; Neoplasms, Experimental; Prodrugs	2000
Caffeine, aminoimidazolecarboxamide and dicoumarol, inhibitors of NAD(P)H dehydrogenase (quinone) (DT diaphorase), prevent both the cytotoxicity and DNA interstrand crosslinking produced by 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) in Walker cells. Biochemical pharmacology, 1989, Nov-15, Volume: 38, Issue:22 Topics: Aminoimidazole Carboxamide; Animals; Antineoplastic Agents; Aziridines; Caffeine; Cross-Linking Reagents; Dicumarol; DNA; Drug Synergism; NAD(P)H Dehydrogenase (Quinone); Neoplasms, Experimental; Quinone Reductases; Rats; Tumor Cells, Cultured; Vitamin K	1989
Hydralazine-induced tumor hypoxia: a potential target for cancer chemotherapy. Journal of the National Cancer Institute, 1989, Apr-19, Volume: 81, Issue:8 Topics: Animals; Antineoplastic Agents; Aziridines; Drug Synergism; Female; Hydralazine; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Misonidazole; Mitomycins; Neoplasms, Experimental; Regional Blood Flow	1989
CB 1954 revisited. I. Disposition kinetics and metabolism. Cancer chemotherapy and pharmacology, 1986, Volume: 16, Issue:1 Topics: Allopurinol; Animals; Aziridines; Azirines; Biotransformation; Brain; Dogs; Drug Interactions; Kinetics; Male; Metabolic Clearance Rate; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Phenobarbital	1986
CB 1954 revisited. II. Toxicity and antitumour activity. Cancer chemotherapy and pharmacology, 1986, Volume: 16, Issue:1 Topics: Animals; Aziridines; Azirines; Colonic Neoplasms; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Interactions; Humans; Lomustine; Mammary Neoplasms, Experimental; Melphalan; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Neoplasms, Experimental; Sarcoma, Experimental	1986